Poor
Not Aligned
Patient Risk:
High
Summary
The AI claims are largely about acyclovir cream and dosing for cold sores/genital herpes in ways not supported by the provided FDA label text (which is for acyclovir oral suspension and does not include cold sores/cold sore timing or any topical cream information). Several oral dosing claims conflict with the provided labeled regimens.
Category Scores
Accurate Statements
Acyclovir oral therapy exists with multiple labeled regimens for herpes zoster and genital herpes (e.g., intermittent therapy and initial genital herpes treatment).
Supported generally by provided label sections under INDICATIONS AND USAGE and DOSAGE AND ADMINISTRATION (e.g., initial genital herpes: 200 mg every 4 hours, 5 times daily for 10 days; intermittent therapy: 200 mg every 4 hours, 5 times daily for 5 days; herpes zoster: 800 mg every 4 hours, 5 times daily for 7 to 10 days).
Unsupported Statements
Acyclovir cream is typically applied five times daily for four days when treating cold sores.
Provided label is for acyclovir oral suspension and does not mention topical acyclovir cream or treatment of cold sores.
If a dose of acyclovir cream is missed, it should be applied as soon as remembered.
Provided label text provided does not include any topical (cream) missed-dose instructions.
If a missed dose is almost time for the next scheduled application, the missed dose should be skipped and the regular schedule resumed.
Provided label text provided does not include any topical (cream) missed-dose instructions.
Acyclovir cream should not be applied extra to make up for a missed dose.
Provided label text provided does not include any topical (cream) missed-dose guidance.
Oral acyclovir for cold sores is taken as a tablet five times daily for five days.
Provided label indicates indications for herpes zoster, genital herpes (initial/recurrent), and chickenpox; it does not mention cold sores, nor a regimen for cold sores.
Acyclovir cream should be started within one hour of the first signs of a cold sore.
Provided label includes timing for herpes zoster (most effective when started within first 48 hours; within 72 hours studied) and for genital herpes recurrence prodrome, but does not mention cold sores or a 'within one hour' requirement; also no cream instructions.
Effectiveness of acyclovir cream drops significantly if treatment begins later in the outbreak cycle.
Provided label provides timing information for herpes zoster and chickenpox (within specified hours/days) but does not provide the specific claim about 'cold sores' or 'cold sore outbreak cycle' nor topical cream effectiveness drop 'significantly.'
No clinical data supports increasing acyclovir cream frequency beyond five times daily.
Provided label text does not address topical cream dosing frequency limits.
Extra applications of acyclovir cream do not speed healing.
Provided label text does not discuss topical cream extra applications or healing speed.
Extra applications of acyclovir cream may raise irritation risk.
Provided label text does not discuss irritation risk related to extra applications of topical cream.
Multiple companies produce generic versions of acyclovir cream, including Teva, Mylan, and Sandoz.
Provided label text does not mention manufacturers or availability of generic brands for any topical cream.
Brand versions such as Zovirax remain available.
Provided label text does not mention brand availability for topical acyclovir cream.
Acyclovir cream patents expired years ago, allowing widespread generic entry.
Provided label text does not provide patent status or generic entry information.
Contradictions
Low
AI Statement
Oral acyclovir for cold sores is taken as a tablet five times daily for five days.
Label Reference
DOSAGE AND ADMINISTRATION in provided label: genital herpes intermittent therapy is 200 mg every 4 hours, 5 times daily for 5 days (but indication is recurrent genital herpes/intermittent therapy, not 'cold sores'); label does not support 'cold sores' indication.
Low
AI Statement
Oral acyclovir for cold sores is taken as a tablet five times daily for five days.
Label Reference
INDICATIONS AND USAGE in provided label: does not include 'cold sores' (no such indication provided).
Low
AI Statement
Oral acyclovir tablet dosing for genital herpes runs five times daily for five to ten days.
Label Reference
DOSAGE AND ADMINISTRATION: the provided label specifies different genital herpes regimens: initial genital herpes is 200 mg every 4 hours, 5 times daily for 10 days; intermittent therapy is 200 mg every 4 hours, 5 times daily for 5 days (not a single 'five to ten days' range description).
Important Omissions
Any FDA-labeled contraindication/warning/renal impairment dosing modification details relevant to oral acyclovir use (e.g., hypersensitivity contraindication; renal impairment dose modification; renal failure risk).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
High
The claims heavily concern topical acyclovir cream and 'cold sores' dosing/timing not present in the provided FDA label text, and include oral dosing that is not clearly matched to labeled indications/regimens. This misalignment can lead to incorrect use outside what the provided label supports.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most claims are about acyclovir cream and cold sores and are absent from the provided FDA label; some oral genital herpes duration descriptions do not match the specific labeled regimens as presented.
Suggested Improvement
Restrict claims to the provided label’s supported indications (herpes zoster, genital herpes initial and recurrent/intermittent therapy, and chickenpox) and to the label’s exact dosing schedules (e.g., genital herpes initial: 10 days; intermittent recurrent: 5 days; herpes zoster: 7–10 days; chickenpox regimens). Remove topical-cream and 'cold sore' claims unless the full corresponding topical product label is provided.